Will new higher-precision troponins lead to clarity or confusion?
- 1 July 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 23 (4) , 292-295
Abstract
Troponins are a cornerstone for the diagnosis of myocardial infarction, assessment of risk and prognosis, and determination of antithrombotic and a revascularization strategy in patients with acute coronary syndromes. Newer assays with higher precision for detection of troponin levels are about to enter clinical practice. The present review discusses the implications of the new assays for patients. Several studies have found that higher-precision troponin assays can determine prognosis at lower cutpoints than currently used in patients with acute coronary syndromes and that about a third of patients 6 months after admission have detectable low levels of troponins. Elevation of troponins can also be detected with the new assays at about 2 h after the onset of ischemic symptoms. This could result in earlier triage to an invasive strategy, and the findings of a repeat normal level at an earlier time point than currently recommended could lead to earlier discharge from the emergency department and cost savings. Elevated high-precision troponin levels have also been found in the community and in patients with heart failure. The new high-precision assays will enable better determination of risk and new paradigms will be developed about detection of elevated troponin levels in patients with chronic stable angina and the normal population. Patients with acute coronary syndromes will be able to be triaged earlier and patient care will be improved.Keywords
This publication has 29 references indexed in Scilit:
- Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?Heart, 2008
- Universal Definition of Myocardial InfarctionJACC, 2007
- Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved SensitivityAmerican Journal of Clinical Pathology, 2007
- Serum and Plasma Cardiac Troponin I 99th Percentile Reference Values for 3 2nd-Generation AssaysClinical Chemistry, 2007
- The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteriesEuropean Heart Journal, 2007
- Redefinition of Myocardial InfarctionCirculation, 2006
- Stratus® CS cardiac troponin I method: performance characteristics including imprecision at low concentrationsClinical Biochemistry, 2004
- Evaluation of Imprecision for Cardiac Troponin Assays at Low-Range ConcentrationsClinical Chemistry, 2004
- Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus RecommendationsClinical Chemistry, 2003
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJACC, 2000